Conversations to bring medical writing topics to the forefront and spark conversations in the wider domain of medical writing.
TriloTalk episodes range from the value of medical writing to apprenticeship and also cover document-specific topics such as lay summaries and how to tame CTD dossiers. Listen on Apple Podcasts, YouTube Podcasts, and Spotify.
Episodes
TriloTalk episode 37 focuses on a specific type of medical device, the drug-delivery system. Writing for drug-delivery systems is all about being fluent in two languages – drugs and devices. Julia Forjanic Klapproth, Senior Partner at Trilogy, Laura Collada, Senior Medical Writing Manager at Trilogy, and Raquel Billiones, Director of Medical Writing at AstraZeneca, talk about this and what medical writers need to understand when crafting these regulatory documents.
Clinical trial transparency is a delicate balance of getting the right data to the right resources at the right time. Senior Partner Lisa Chamberlain James sits down with the President of Holtzople Consulting, Julie Holtzople, to discuss how to do just that. They discuss standardizing information for researchers, building trust, advice for best practices, and whether all this transparency is legally mandated – or simply the right thing to do.
The demand for experienced medical writers is outpacing the availability of experienced writers. In TriloTalk episode 35, Julia Forjanic Klapproth, Senior Partner at Trilogy, and Kim Jochman, Senior Director of Medical Writing at Merck, raise awareness of two new essential AMWA resources: the apprentice program framework and the job leveling framework. As members of the workstreams who developed these, Julia and Kim bring insights and the rationale from behind the scenes. Tune in and learn about these important initiatives for the medical writing community.
For episode 34 of the TriloTalk podcast, Lisa Chamberlain James, Senior Partner at Trilogy, sits down with the AI Agent expert Nikesh Shah, VP and Global Head, Generative AI at Indegene. They discuss everything you need to know about AI Agents – the day-to-day usage, project confidentiality, when it will become mainstream, which industries are using it now, and how it will enrich our lives. It’s an episode you don’t want to miss!
This episode focuses on writing for medical devices. Playing Sherlock Holmes, conducting usability studies, following regulations, working closely with the manufacturers and much more are all in a day’s work when writing for devices. Listen to Trilogy’s medical writing managers, Heidi Chapman and Laura Collada, and Senior Partner, Julia Forjanic Klapproth, discuss the similarities and differences between writing for devices and writing for drugs. Listen up!
The Informed Consent Form is a participant’s first impression of a clinical trial so Lisa Chamberlain James and Ros Cheetham sit down to discuss how to make it the best it can be. Learn about the layout, formatting, crafting tips, where plain language fits in, and its future.
Join Julia Forjanic Klapproth as she gives a useful overview of what everyone is talking about these days – AI agents. You’ll hear about the benefits they bring and their limitations, how it will dramatically change everyone’s day-to-day work, and what this means for the medical writing world.
It’s International Day of Women and Girls in Science! To celebrate, TriloTalk episode 30 is a conversation with Trilogy’s two female Senior Partners discussing what sparked their interest in science, barriers to entry (or lack thereof), clinical research gaps, female representation in the medical writing industry and more. Listen up!
The rapidly growing industry of regulatory medical writing calls for a 2025 prediction podcast! Listen up for “What’s Hot and What’s Not” from our experts Lisa Chamberlain James, Julia Forjanic Klapproth and Sonica Batra and get a glimpse of what Trilogy, an Indegene Company and Indegene will be up to this year.
Long time friends and industry colleagues, Lisa Chamberlain James with Trilogy and Cheryl Roberts with BioMarin Pharmaceutical sit down to discuss orphan drugs. They go over clinical trial hurdles, key incentives for health authorities, the medical writing process and start with an important question – why are orphan drugs called orphan drugs? Find out on episode 28 of TriloTalk!
What’s an orphan drug? Orphan drug – Trilogy Writing & Consulting
Join Julia Forjanic Klapproth, Barbara Boggetti, and Bhawna Basin as they take a closer look into Clinical Overviews. Since many agree it’s one of the most interesting documents medical writers prepare, they dive right into many topics like strategy, FDA vs EMA requirements, graphics, working with sponsors, and even page count challenges. Listen up!
What’s a Clinical Overview? Clinical Overview – Trilogy Writing & Consulting
Welcome back to TriloTalk! In this episode, Lisa Chamberlain James from Trilogy and Vladimir Penkrat and Ritesh Dogra from Indegene dive into the role and future of lay summaries. AI technology, new EUCTR requirements, graphic creation, and much more will affect how medical writers create patient-friendly language documents. Tune in to gain valuable insights and tips on how to navigate this changing environment.
Read more about lay summaries here: Lay Summary Resources – Trilogy Writing & Consulting
In this episode, Julia Forjanic Klapproth and Lisa Chamberlain James from Trilogy and Vladimir Penkrat and Tarun Mathur from Indegene chat about the intersection of AI and medical writing. They cover historical evolution, current needs, automation strategies, essential skills, regulatory compliance, and unique use cases. Tune in to catch the insights and join the conversation!
Read more about AI and medical writing: AI Resources – Trilogy Writing & Consulting
Welcome to Trilotalk Episode 24! In this episode, Douglas and Nidhi will take you through an overview of the recently introduced EU-CTR (Clinical Trial Regulation) – a hot topic in our industry these days! As medical writers, we need to be aware of not only what the EU-CTR is but also how it impacts the documents we often write. Join us to find out more about it! We will talk about what the EU-CTR is, the pros and cons of the new process, how a CTA in the EU is structured, and touch upon associated transparency and public disclosure requirements.
Welcome back to TriloTalk! As promised, we are continuing the conversation about buzzwords in medical writing. In this episode, our guests Lisa and Art explore the topic of medical writing and artificial intelligence in Part II of our series, ‘Speaking of Buzzwords in Medical Writing’. Beyond mere catchphrases, they will reflect on the trending use of generative AI, its benefits and potential pitfalls, and the evolving role of medical writers. Happy podcasting!
Read more about AI and medical writing: AI Resources – Trilogy Writing & Consulting
In this episode, Lisa Chamberlain James, Senior Partner at Trilogy Writing & Consulting, and Art Gertel, Principal at MedSciCom, discuss the pivotal role of patients in pharmaceutical decision-making. Despite knowing the importance of patient-centricity, their perspectives are frequently overlooked in crucial stages of drug development. How can pharmaceutical companies integrate patients’ unique insights to enhance their processes? Tune in as they engage in this vital discussion.
Interested in exploring the topic ‘Communicating with patients’ deeper and beyond our podcast episode? Here’s the link to our dedicated Medical Writing Supplement of ICT on this very topic. Also, stay tuned for Part II of Lisa and Art’s conversation in Episode 23, coming up in April 2024.
Join Nidhi Johal, Director of Medical Writing for North America at Trilogy Writing & Consulting, and Heidi Chapman, Medical Writing Manager at Trilogy in a conversation about a topic that resonates with professionals across the industry – medical writer burnout. In this episode, Nidhi and Heidi draw from their own experiences, sharing personal stories, exploring the signs of burnout, and helping listeners identify red flags early on. From setting boundaries to embracing self-care practices, they discuss practical strategies they’ve learned to prevent burnout, ensuring a healthy work-life balance. Whether you’re a seasoned writer or just stepping into the world of medical writing, this episode provides valuable insights to keep you thriving in this profession. Happy listening!
Read here how to achieve a work-life balance as a medical writer: Achieving a Work-Life Balance as Medical Writers – Trilogy Writing & Consulting
In this episode, Julia and Lisa take a deep dive into General Medical Writing Principles. Join them as they navigate through a diverse range of topics that are crucial in the everyday practice of crafting clear and concise regulatory documents. Our hosts will generously share their personal insights, experiences, and invaluable tips that have positioned them as Masters in the field of medical writing. Happy podcasting!
In this episode, Lisa Chamberlain James, Senior Partner at Trilogy Writing & Consulting, and Magnolia Correa, Marketing Communications Manager at Trilogy Writing & Consulting, delve into their shared passion for patient communication. They explore this topic from their different perspectives and discuss how medical writers contribute to enhancing health outcomes by crafting clear and impartial documents intended for the general public.
Join Julia and Jonathan for the 2nd part of a discussion dedicated to the development of Clinical Study Protocols as they delve into the intricacies of writing these crucial documents. In this discussion, they explore the level of involvement a writer should have to ensure a well-written protocol. Tune in to gain valuable insights and guidance on creating effective protocols that drive successful clinical studies.